Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy-Reference-Cited by-同舟云学术

Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy

Published:2020-10 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Fasulo Vittorio,Cowan Janet E.,Maggi Martina^ORCID,Washington Samuel L.^ORCID,Nguyen Hao G.,Shinohara Katsuto^ORCID,Lazzeri Massimo,Casale Paolo,Carroll Peter R.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference29 articles.

1. The diagnosis and treatment of prostate cancer: a review;Litwin;JAMA,2017

2. Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort;Tosoian;Eur Urol,2020

3. Active surveillance in intermediate-risk prostate cancer;Klotz;BJU Int,2020

4. A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings;Luzzago;BJU Int,2020

5. Active surveillance for the management of localized prostate cancer (Cancer Care Ontario guideline): American Society of Clinical Oncology clinical practice guideline endorsement;Chen;J Clin Oncol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes;BJUI Compass;2023-06-21

2. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control;JAMA Surgery;2023-04-01

3. Experience in Multiparametric magnetic resonance prior to targeted prostate biopsy: a pick of the iceberg for cancer detection?;Minerva Urology and Nephrology;2023-03

4. Comment on: "Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society";Minerva Urology and Nephrology;2023-01

5. Racial differences in circulating mitochondria‐derived peptides may contribute to prostate cancer health disparities;The Prostate;2022-07-05